Expert Review of Pharmacoeconomics & Outcomes Research

metrics 2024

Delivering Impactful Insights for Optimal Healthcare Solutions

Introduction

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

Metrics 2024

SCIMAGO Journal Rank0.67
Journal Impact Factor1.80
Journal Impact Factor (5 years)2.20
H-Index61
Journal IF Without Self1.80
Eigen Factor0.00
Normal Eigen Factor0.53
Influence0.65
Immediacy Index0.30
Cited Half Life7.30
Citing Half Life5.60
JCI0.57
Total Documents1866
WOS Total Citations2470
SCIMAGO Total Citations7305
SCIMAGO SELF Citations460
Scopus Journal Rank0.67
Cites / Document (2 Years)1.79
Cites / Document (3 Years)2.26
Cites / Document (4 Years)2.17

Metrics History

Rank 2024

Scopus

Health Policy in Medicine
Rank #106/310
Percentile 65.81
Quartile Q2
Pharmacology (medical) in Medicine
Rank #124/272
Percentile 54.41
Quartile Q2

IF (Web Of Science)

HEALTH CARE SCIENCES & SERVICES
Rank 100/174
Percentile 42.80
Quartile Q3
HEALTH POLICY & SERVICES
Rank 72/118
Percentile 39.40
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 240/354
Percentile 32.30
Quartile Q3

JCI (Web Of Science)

HEALTH CARE SCIENCES & SERVICES
Rank 112/175
Percentile 36.00
Quartile Q3
HEALTH POLICY & SERVICES
Rank 83/119
Percentile 30.25
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 210/354
Percentile 40.68
Quartile Q3

Quartile History

Similar Journals

BMC HEALTH SERVICES RESEARCH

Driving evidence-based change in health services.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

AMERICAN JOURNAL OF MANAGED CARE

Driving innovation in health policy and managed care.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

MEDICAL DECISION MAKING

Transforming theory into practice for healthcare excellence.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Journal of Health Economics and Outcomes Research

Exploring the economics of health for a better tomorrow.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

Journal of Pharmaceutical Health Services Research

Transforming challenges into opportunities in pharmaceutical health.
Publisher: OXFORD UNIV PRESSISSN: 1759-8885Frequency: 4 issues/year

Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.

Gesundheitsoekonomie und Qualitaetsmanagement

Fostering Excellence in Health Economics and Quality Management
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

HEALTH TECHNOLOGY ASSESSMENT

Transforming health policy with innovative technology insights.
Publisher: NIHR JOURNALS LIBRARYISSN: 1366-5278Frequency:

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Journal of Comparative Effectiveness Research

Unlocking the potential of healthcare interventions.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Health Services Management Research

Shaping the Landscape of Health Policy with Cutting-Edge Studies
Publisher: SAGE PUBLICATIONS LTDISSN: 0951-4848Frequency: 4 issues/year

Health Services Management Research is a premier academic journal published by SAGE PUBLICATIONS LTD, focusing on critical areas within the health policy domain. With an ISSN of 0951-4848 and E-ISSN 1758-1044, this UK-based journal has been a valuable resource for over three decades, converging from 1988 to 2024. Recognized for its contribution to the field, it holds a commendable Q2 quartile ranking, positioning it in the top 35% of journals in Health Policy, reflecting its significant impact within the academic community, as evidenced by its rank of 109 out of 310 in Scopus rankings, placing it in the 65th percentile. The journal aims to foster innovative research that addresses the complexities of health services management, making it an indispensable resource for researchers, professionals, and students dedicated to improving health systems. Although it currently does not offer Open Access, the journal remains committed to advancing knowledge and practice in health policy management through rigorous peer-reviewed articles, case studies, and evidence-based analyses.

Exploratory Research in Clinical and Social Pharmacy

Navigating the future of pharmacy through exploratory research.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.